Feb. 06, 2018News & Opinions
Pharmaceutical companies’ interest in buying consumer health businesses is waning, with more players interested in shedding the activities than acquiring them, reports suggest.
Jan. 18, 2018News & Opinions
GlaxoSmithKline (GSK), the UK’s largest drugmaker in terms of sales, is rumored to be preparing a bid for compatriot Vectura, an inhaled airways disease-focused player. The two companies already collaborate on respiratory therapies.
Jan. 12, 2018News & Opinions
A management reshuffle at the UK’s largest drugmaker, GlaxoSmithKline has caught the market’s attention, especially as it was carried through by closely watched CEO Emma Walmsley, who took over from Andrew Witty in spring 2017 ...
Jan. 03, 2018News & Opinions
UK drugmaker GlaxoSmithKline (GSK) has expanded its stake in its Saudi subsidiary Glaxo Saudi Arabia Limited (GSAL) by 26% to 75%.
Dec. 05, 2017News & Opinions
As a UK Parliament-select committee prepared for a public evidence session on Dec. 5, examining scenarios for trading arrangements with the UK post-Brexit, reports were circulating that investments worth “billions of pounds” ...
Nov. 29, 2017News & Opinions
The US Food and Drug Administration (FDA) has approved a new two-drug regimen for HIV that reports suggest could shake up the $22 billion market for products to treat the immune deficiency.
Oct. 24, 2017News & Opinions
The US Food and Drug Administration on Oct. 20 approved Shingrix, the long awaited recombinant, adjuvant new shingles vaccine manufactured by UK drugmaker Glaxo SmithKline (GSK). Days earlier, Canada gave the green light. GSK is also ...
Oct. 18, 2017News & Opinions
As generics pricing pressure increases, Swiss drugmaker Novartis said it will close a US plant at Broomfield, Colorado, owned by its Sandoz subsidiary and employing 450 people. It was initially unclear how many jobs might be lost in the ...
Jul. 26, 2017News & Opinions
US Merck’s shingles (herpes zoster) vaccine Zostavax continues to be the target of legal action at a time when the drugmaker is already facing the prospect of competition from GlaxoSmithKline’s (GSK) vaccine Shingrix.
Jul. 10, 2017News & Opinions
UK drugmaker GlaxoSmithKline (GSK) is to collaborate with artificial intelligence (AI) company Exscientia. The partnership will see Exscientia combine its AI-enabled platform with GSK’s expertise to discover novel and selective small ...
The latest information directly via newsletter.